Mitochondrial Quality Control and Pathogenic Signaling Networks in Parkinson's Disease

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Parkinson's disease (PD) is a prevalent neurodegenerative disorder lacking effective treatments.
• Mitochondrial dysfunction is implicated in PD etiology, though its exact role remains unclear.
• Mitochondrial quality control (MQC) mechanisms, including mitophagy, dynamics, and proteostasis, are vital for mitochondrial health.

Purpose of the Study:

• To examine mitochondrial dysfunction in Parkinson's disease through the lens of MQC.
• To explore the role of mitochondrial reactive oxygen species (mtROS) and damage-associated molecular patterns (mtDAMPs) in PD pathogenesis.
• To review current and emerging therapeutic strategies targeting mitochondrial dysfunction and neuroinflammation in PD.

Main Methods:

• Review of existing literature on mitochondrial dysfunction in Parkinson's disease.
• Analysis of the roles of PINK1/Parkin-mediated mitophagy, mitochondrial dynamics, and proteostasis.
• Investigation of mtROS, mtDAMPs, and their impact on cellular processes and neuroinflammation.

Main Results:

• Compromised MQC leads to accumulation of damaged mitochondria, oxidative stress, and aberrant signaling in PD.
• mtROS exacerbate PD pathology by promoting α-synuclein aggregation and dopamine oxidation.
• mtDAMPs, particularly mitochondrial DNA, can trigger innate immune pathways, causing neuroinflammation.

Conclusions:

• The PINK1/Parkin pathway is critical for maintaining mitochondrial homeostasis in PD.
• Emerging research highlights the role of m⁶A RNA modification in regulating mitochondrial stress.
• Combination therapies targeting mitophagy, neuroinflammation, and mitochondrial protection show promise for future PD treatment.